EQS-News / 16/04/2020 / 10:37 UTC+8
[Immediate Release] 16 April 2020
Yestar Healthcare Holdings Company Limited
(Stock code: 2393.HK)
Exporting Disposable Medical Masks to the US, Japan, Singapore and Indonesia
Planning to Increase Production Capacity and
Introduce Medical N95 Production Lines
(Hong Kong - 16 April 2020) Yestar Healthcare Holdings Company Limited
("Yestar" or the "Company" together with its subsidiaries, the "Group",
stock code: 2393.HK) announces that its high quality standard disposable
medical mask product commenced production in March. As of today, the
products have been exported to the United States of America, Japan,
Singapore, Indonesia etc., contributing strategic materials to fight the
pandemic of COVID-19.
With a planned monthly production capacity of 3 million pieces, Yestar
Healthcare's high quality standard disposable medical mask production line
has been officially put into operation by the end of March 2020. Many
countries around the globe are suffering from COVID-19 outbreak at the
moment. As an effective tool to prevent the spread of the virus, mask supply
is in great demand. In view of the situation, Yestar Healthcare plans to add
an additional production line in the near future, planning to increase the
disposable medical mask production capacity to 4 million pieces per month.
Mr. James Hartono, the Chairman of Yestar Healthcare, stated, "In response
to the outbreak, Yestar Healthcare has introduced the "84 Disinfectant" and
disposable medical mask in February and March respectively, which has
demonstrated the solid foundation of our capabilities in research and
development, production, managements, system and medical distribution
network. While increasing the production capacity of disposable medical
masks, we are also working on to produce medical N95 masks in May with a
planned monthly capacity of 3.7 million pieces. Medical N95 masks provides a
stronger protection by filtering out more virions, which are mainly used by
medical professionals. As we are facing a shortage of medical N95 worldwide,
Yestar Healthcare will mobilize all available resources to launch the
product as soon as possible, helping the frontline medical professionals in
fight against the virus outbreak."
- End -
About Yestar Healthcare Holdings Company Limited
Yestar Healthcare Holdings Company Limited (formerly known as Yestar
International Holdings Company Limited) is the largest distributor of
Fujifilm products and one of the largest distributor of Roche Diagnostics in
the PRC. Yestar has been transformed itself into a high margin medical
consumables manufacturer and distributor in the PRC since 2014. Targeting
the booming domestic healthcare industry, the core business of the Group
focuses on high margin and fast-moving healthcare consumables namely, IVD
products and medical imaging products.
For enquiries, please contact:
DLK Advisory
Michelle Shi (michelleshi@dlkadvisory.com)
Rachel Chung (rachelchung@dlkadvisory.com)
Tel: +852 2857 7101
Fax: +852 2857 7103
Document: https://eqs-cockpit.com/c/fncls.ssp?u=RRPIIAAXMA [1]
Document title: 2393_N95 mask_20200416_EN
16/04/2020 Dissemination of a Financial Press Release, transmitted by EQS
Group.
The issuer is solely responsible for the content of this announcement.
Media archive at www.todayir.com
1: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=ab48025ac91a8075a8990f7525f3f3f5&application_id=1022587&site_id=vwd&application_name=news
(END) Dow Jones Newswires
April 15, 2020 22:37 ET (02:37 GMT)
© 2020 Dow Jones News
